Skip to main content
Formycon AG logo

Formycon AG — Investor Relations & Filings

Ticker · FYB ISIN · DE000A1EWVY8 LEI · 39120005TZ76GQOY8Z19 F Manufacturing
Filings indexed 363 across all filing types
Latest filing 2018-03-23 Annual Report
Country DE Germany
Listing F FYB

About Formycon AG

https://www.formycon.com/en/

Formycon AG is an independent, globally operating biopharmaceutical company specializing in the development of high-quality biosimilars. As a pure-play biosimilar developer, the company focuses on creating follow-on products for complex biopharmaceutical medicines after their patent protection has expired. The core mission is to enhance patient access to safe, effective, and affordable biologic therapies. Formycon's development activities are concentrated in therapeutic areas with high medical need, including ophthalmology and immunology. The company manages the entire development process, from analytics and process development to clinical trials and regulatory approval submissions for its biosimilar candidates.

Recent filings

Filing Released Lang Actions
Datum:23.03.2018
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) and 'Lagebericht' (Management Report) for Formycon AG for the fiscal year 2016. It contains detailed financial data, balance sheets, income statements, and management analysis of the company's performance, business model, and outlook. As it covers the full fiscal year and provides comprehensive financial reporting, it is classified as an Annual Report (10-K). FY 2016
2018-03-23 German
Formycon AG: Formycon Reports Operating and Financial Results for the Third Quarter of 2017
Earnings Release Classification · 100% confidence The document is titled "Formycon Reports Operating and Financial Results for the Third Quarter of 2017" and explicitly details financial figures (turnover, EBITDA, EBIT, net earnings) for the first nine months of 2017, along with operational updates on biosimilar projects. This content structure—a press release announcing specific financial performance for a period shorter than a full year (Q3/Nine Months)—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it provides the key financial highlights and management commentary immediately upon release, it fits the definition of an Earnings Release (ER). It is not a comprehensive, formal regulatory filing like a 10-K, nor is it merely an announcement of a report's publication (RPA). 9M 2017
2017-11-27 English
Formycon AG: Formycon Sets Course for the Future and Confirms Management Board Members until mid-2022
Board/Management Information Classification · 99% confidence The document is a press release dated November 16, 2017, announcing the extension of contracts for the CEO and CFO of Formycon AG until mid-2022. This content directly relates to changes or confirmations regarding the company's senior management team. This aligns perfectly with the definition for Board/Management Information (MANG). It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV).
2017-11-16 English
Halbjahresabschluss 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresbericht 2017' (Half-Year Report 2017) and contains a 'Brief an die Aktionäre' (Letter to Shareholders), detailed business reports, and financial structure information. It covers the performance and developments of the company for the first six months of the fiscal year. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial and operational analysis for a period shorter than a full fiscal year. H2 2017
2017-10-06 German
Formycon AG: Formycon Reports Financial and Operating Results for the First Half Year of 2017
Report Publication Announcement Classification · 95% confidence The document is a press release announcing the financial results for the first half of 2017. It provides a summary of key financial highlights (turnover, period results, liquid assets) but explicitly directs the reader to an external URL for the 'full half-year report'. According to the 'Menu vs Meal' rule, since this is an announcement of a report rather than the full report itself, it is classified as a Report Publication Announcement. H1 2017
2017-09-29 English
Formycon AG: Formycon Publishes Figures for the First Quarter of 2017
Earnings Release Classification · 100% confidence The document is titled "Formycon Publishes Figures for the First Quarter of 2017" and contains key financial performance indicators (sales revenues, EBITDA, liquid assets) specifically for the first quarter. The header also mentions "Key word(s): Quarter Results/Interim Report". This content strongly indicates a comprehensive financial report covering a period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not just a brief announcement of publication (RPA) because it contains substantial financial details, nor is it the Annual Report (10-K). Q1 2017
2017-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.